The Scientist

» drug development, immunology and evolution

Most Recent

Using simulations, scientists report that a mixture of termites and plant competition may be responsible for the strange patterns of earth surrounded by plants in the Namib desert. 

2 Comments

image: Baboons Can Make Sounds Found in Human Speech

Baboons Can Make Sounds Found in Human Speech

By | January 13, 2017

The findings suggest language may have started to evolve millions of years earlier than once thought.  

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Adaptation, Island Style

Adaptation, Island Style

By | January 3, 2017

Anole lizards inhabiting the Caribbean islands display some of the key principles of evolution.

0 Comments

The small lizards adapted to unique niches among dozens of isles.

1 Comment

image: How an Invasive Bee Managed to Thrive in Australia

How an Invasive Bee Managed to Thrive in Australia

By | January 1, 2017

The Asian honeybee should have been crippled by low genetic diversity, but thanks to natural selection it thrived.

1 Comment

The public may still believe that male-specific traits, such as high testosterone levels, lead to many of the gender inequalities that exist in society, but science tells a different story.

2 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. March for Science: Dispatches from Washington, DC
AAAS